Gensight Biologics SA
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Gensight Biologics SA
Gensight Biologics SA is a clinical-stage biotechnology group discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system. The company's pipeline leverages two core technology platforms, the Mitochondrial Targeting Sequence and Optogenetics, to help preserve or restore vision in patients suffering from severe degenerative retinal diseases. The group's focus is on ophthalmology, where it develops product candidates to restore eyesight to patients suffering from retinal diseases. The product candidate, LUMEVOQ, was developed using the MTS technology platform and is designed to treat LHON by restoring the function of retinal diseases resulting from mutations.
/ 
Others were interested in
Frequently asked questions
To buy Gensight Biologics SA stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Gensight Biologics SA by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Gensight Biologics SA is SIGHT:xpar. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Gensight Biologics SA has its primary listing on Euronext Paris. You can trade Gensight Biologics SA with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Gensight Biologics SA is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Gensight Biologics SA as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Gensight Biologics SA.